Scarica l'app Stockscreener
250.52
0.09%
-0.23
Dopo l'orario di chiusura:
249.60
-0.92
-0.37%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$250.75
Aprire:
$249.23
Volume 24 ore:
1.21M
Relative Volume:
1.13
Capitalizzazione di mercato:
$36.56B
Reddito:
$5.26B
Utile/perdita netta:
$1.44B
Rapporto P/E:
25.64
EPS:
9.7713
Flusso di cassa netto:
$1.76B
1 W Prestazione:
+2.37%
1M Prestazione:
-3.46%
6M Prestazione:
+3.16%
1 anno Prestazione:
+2.76%
Intervallo 1D:
$248.45
$251.57
Intervallo di 1 settimana:
$241.81
$254.00
Portata 52W:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
Nome
Resmed Inc
Settore
Industria
Telefono
(858) 746-2400
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Confronta RMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
250.52 | 36.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
ISRG
Intuitive Surgical Inc
|
568.48 | 199.09B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
190.96 | 55.24B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
76.25 | 37.63B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
WST
West Pharmaceutical Services Inc
|
273.99 | 19.50B | 2.96B | 487.70M | 344.00M | 6.6758 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Iniziato | Citigroup | Buy |
| 2025-09-02 | Aggiornamento | CLSA | Hold → Outperform |
| 2025-07-15 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | Iniziato | Morgan Stanley | Overweight |
| 2025-01-16 | Iniziato | Goldman | Buy |
| 2025-01-10 | Iniziato | Piper Sandler | Neutral |
| 2024-12-13 | Iniziato | Stifel | Hold |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-09-18 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | Downgrade | Needham | Buy → Hold |
| 2024-06-25 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-06-24 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-05 | Downgrade | UBS | Buy → Neutral |
| 2023-08-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | Iniziato | UBS | Buy |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-01-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-09-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-08-15 | Downgrade | CLSA | Buy → Outperform |
| 2022-08-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-01-28 | Aggiornamento | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-01-13 | Aggiornamento | CLSA | Outperform → Buy |
| 2022-01-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-10-22 | Aggiornamento | CLSA | Underperform → Outperform |
| 2021-08-02 | Downgrade | CLSA | Outperform → Sell |
| 2021-08-02 | Downgrade | Needham | Buy → Hold |
| 2021-07-28 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-14 | Iniziato | RBC Capital Mkts | Underperform |
| 2021-06-28 | Downgrade | Citigroup | Buy → Neutral |
| 2021-06-22 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-06-22 | Iniziato | Robert W. Baird | Neutral |
| 2021-06-21 | Reiterato | Needham | Buy |
| 2021-06-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-09 | Aggiornamento | CLSA | Sell → Outperform |
| 2021-05-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-30 | Downgrade | Citigroup | Buy → Neutral |
| 2021-03-16 | Aggiornamento | Needham | Hold → Buy |
| 2020-11-02 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-10-27 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-01 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Iniziato | CLSA | Underperform |
| 2020-01-31 | Downgrade | UBS | Buy → Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Perform |
| 2019-11-22 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | Aggiornamento | UBS | Neutral → Buy |
| 2019-07-16 | Downgrade | UBS | Buy → Neutral |
| 2019-05-06 | Aggiornamento | UBS | Neutral → Buy |
| 2019-04-18 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-01-25 | Downgrade | Goldman | Buy → Neutral |
| 2019-01-25 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | Iniziato | Goldman | Buy |
Mostra tutto
Resmed Inc Borsa (RMD) Ultime notizie
ResMed Inc. Announces Change in Board Leadership - TipRanks
ResMed CFO Acquires Performance-Based Shares - TipRanks
ResMed Director Increases Stake with New Stock Acquisition - TipRanks
ResMed Inc. Expands Equity Incentive Plan with Additional Share Registration - MSN
IDEXX Laboratories Vs ResMed: Which Stock Could Rally? - Forbes
ResMed Inc. Expands Employee Stock Purchase Plan with New Share Registration - MSN
Swiss National Bank Boosts Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Acquired by Legal & General Group Plc - MarketBeat
Handelsbanken Fonder AB Cuts Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc RME Stock Analysis and ForecastMomentum Stock Picks & Minimal Capital Appreciation - earlytimes.in
ResMed Inc. $RMD Shares Purchased by Mediolanum International Funds Ltd - MarketBeat
Prudential PLC Sells 39,187 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Acquired by Empowered Funds LLC - MarketBeat
Ensign Peak Advisors Inc Reduces Position in ResMed Inc. $RMD - MarketBeat
Is ResMed's 10% Year-to-Date Gain Justified After Recent Industry Headlines? - Yahoo Finance
Martin Currie Ltd. Has $35.12 Million Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Acquired by Entropy Technologies LP - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Has $5.64 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc Updates Dividend Exchange Rate for CDI Holders - MSN
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know - Finviz
[Form 4] RESMED INC Insider Trading Activity - Stock Titan
[S-8] RESMED INC Employee Benefit Plan Registration | RMD SEC FilingForm S-8 - Stock Titan
Traders Buy Large Volume of Put Options on ResMed (NYSE:RMD) - MarketBeat
Will ResMed Inc. stock benefit from infrastructure spendingJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com
ResMed Inc. $RMD Shares Purchased by Vanguard Group Inc. - MarketBeat
Nomura Asset Management Co. Ltd. Purchases 2,186 Shares of ResMed Inc. $RMD - MarketBeat
Can ResMed Inc. stock withstand sector downturnsQuarterly Market Review & Long-Term Growth Portfolio Plans - newser.com
Will ResMed Inc. (RME) stock announce special dividendOptions Play & Consistent Profit Focused Trading Strategies - newser.com
ResMed Inc. (RMD) Announces Key Amendments to Incentive and Stoc - GuruFocus
ResMed Streamlines Governance at Annual Meeting - TipRanks
[8-K] RESMED INC Reports Material Event | RMD SEC FilingForm 8-K - Stock Titan
Should Strong Q1 Results and New Industry Trends Prompt Action From ResMed (RMD) Investors? - Sahm
July 2026 Options Now Available For ResMed (RMD) - Nasdaq
Is ResMed Inc. stock attractive for passive investorsWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
Are Wall Street Analysts Predicting ResMed Stock Will Climb or Sink? - MSN
Universal Beteiligungs und Servicegesellschaft mbH Has $23.87 Million Stock Position in ResMed Inc. $RMD - MarketBeat
Analysts Issue Forecasts for ResMed's Q2 Earnings (NYSE:RMD) - MarketBeat
Will ResMed Inc. (Common Stock) (RMEA) stock top growth indexes2025 Market Overview & Fast Moving Market Watchlists - newser.com
ResMed Inc Reports Change in Beneficial Ownership - MSN
What makes ResMed Inc. stock appealing to growth investors2025 Volatility Report & Daily Oversold Bounce Ideas - newser.com
ResMed Inc. $RMD Holdings Lifted by SG Americas Securities LLC - MarketBeat
Creative Planning Purchases 1,765 Shares of ResMed Inc. $RMD - MarketBeat
How strong is ResMed Inc. (Common Stock) (RMEA) stock earnings growth2025 Valuation Update & AI Based Buy and Sell Signals - newser.com
Is ResMed Inc. (Common Stock) (RMEA) stock in buy zone after pullbackJuly 2025 Action & Weekly Setup with High ROI Potential - newser.com
Can ResMed Inc. stock hold up in economic slowdownTrade Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Is ResMed Inc. stock positioned for digital growth era2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
ResMed Inc. Reports Changes in Beneficial Ownership - MSN
Can ResMed Inc. (Common Stock) (RMEA) stock attract analyst upgradesQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Why analysts remain bullish on ResMed Inc. stockChart Signals & Fast Exit and Entry Trade Guides - newser.com
Is ResMed Inc. stock vulnerable to regulatory risksMarket Trend Summary & Daily Technical Forecast Reports - newser.com
How ResMed Inc. (RME) stock behaves in tightening cyclesStop Loss & AI Driven Price Forecasts - newser.com
Resmed Inc Azioni (RMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
1.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):